Ohcanbohtosat - Anne E. Lykkesfeldt
- Čájehuvvo 1 - 12 / 12
-
1
-
2
Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors Dahkki Thomas Frogne, Anne‐Vibeke Lænkholm, Maria Lyng, Katrine L. Henriksen, Anne E. Lykkesfeldt
Almmustuhtton 2009Artigo -
3
-
4
Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays Dahkki Katrine L. Henriksen, Birgitte Rasmussen, Anne E. Lykkesfeldt, Susann Møller, Bent Ejlertsen, Henning T. Mouridsen
Almmustuhtton 2006Artigo -
5
High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer Dahkki Carla L. Alves, Daniel Eliáš, Maria Lyng, Martin Bak, Tove Kirkegaard, Anne E. Lykkesfeldt, Henrik J. Ditzel
Almmustuhtton 2016Artigo -
6
Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer wi... Dahkki Alexandra Léary, Suzanne Drury, Simone Detre, Sunil Pancholi, Anne E. Lykkesfeldt, Lesley‐Ann Martin, Mitch Dowsett, Stephen Johnston
Almmustuhtton 2010Artigo -
7
Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy Dahkki Daniel Eliáš, Henriette Vever, Anne‐Vibeke Lænkholm, Morten F. Gjerstorff, Christina W. Yde, Anne E. Lykkesfeldt, Henrik J. Ditzel
Almmustuhtton 2014Artigo -
8
Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like pro... Dahkki Xue Lin, Jian Li, Guangliang Yin, Qian Zhao, Daniel Eliáš, Anne E. Lykkesfeldt, Jan Stenvang, Nils Brünner, Jun Wang, Huanming Yang, Lars Bolund, Henrik J. Ditzel
Almmustuhtton 2013Artigo -
9
A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells Dahkki Susan Thrane, ASTRID M. PEDERSEN, M B H Thomsen, T Kirkegaard, Birgitte Rasmussen, Anne Katrine Duun‐Henriksen, Anne‐Vibeke Lænkholm, Martin Bak, Anne E. Lykkesfeldt, Christina W. Yde
Almmustuhtton 2014Artigo -
10
Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling Dahkki Martin J. Larsen, Torben A. Kruse, Qihua Tan, Anne‐Vibeke Lænkholm, Martin Bak, Anne E. Lykkesfeldt, Kristina P. Sørensen, Thomas van Overeem Hansen, Bent Ejlertsen, Anne‐Marie Gerdes, Mads Thomassen
Almmustuhtton 2013Artigo -
11
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant Dahkki Thomas Frogne, Rikke Vicki Benjaminsen, Katrine Sonne‐Hansen, Boe Sandahl Sørensen, Ebba Nexø, Anne‐Vibeke Lænkholm, Louise M. Rasmussen, David J. Riese, Patricia de Crémoux, Jan Stenvang, Anne E. Lykkesfeldt
Almmustuhtton 2008Artigo -
12
FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance Dahkki Julie Millour, Demetra Constantinidou, Alexandra Stavropoulou, Miranda Wilson, Stephen S. Myatt, Jimmy M-M. Kwok, Kavitta Sivanandan, R. Charles Coombes, René H. Medema, Johan Hartman, Anne E. Lykkesfeldt, Eric W.‐F. Lam
Almmustuhtton 2010Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Cancer
Biology
Breast cancer
Cancer research
Internal medicine
Medicine
Genetics
Oncology
Tamoxifen
Endocrinology
Estrogen receptor
Gene
Gene expression
Receptor
Bioinformatics
Cell biology
Endocrine system
Fulvestrant
Hormone
Kinase
Antiestrogen
Biochemistry
Cell culture
Cell cycle
Cell growth
Chemistry
Epidermal growth factor
Estrogen
Gene expression profiling
Signal transduction